Geron Corp (GERN)
3.57
-0.01
(-0.28%)
USD |
NASDAQ |
Apr 25, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Geron SG&A Expense (Quarterly): 21.40M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.40M |
September 30, 2023 | 18.35M |
June 30, 2023 | 16.49M |
March 31, 2023 | 12.89M |
December 31, 2022 | 13.84M |
September 30, 2022 | 15.64M |
June 30, 2022 | 7.443M |
March 31, 2022 | 6.699M |
December 31, 2021 | 7.872M |
September 30, 2021 | 7.256M |
June 30, 2021 | 7.059M |
March 31, 2021 | 7.478M |
December 31, 2020 | 7.088M |
September 30, 2020 | 6.51M |
June 30, 2020 | 5.96M |
March 31, 2020 | 6.12M |
December 31, 2019 | 5.256M |
September 30, 2019 | 4.994M |
June 30, 2019 | 5.191M |
March 31, 2019 | 5.452M |
December 31, 2018 | 4.883M |
September 30, 2018 | 4.263M |
June 30, 2018 | 4.246M |
March 31, 2018 | 5.315M |
December 31, 2017 | 5.454M |
Date | Value |
---|---|
September 30, 2017 | 4.77M |
June 30, 2017 | 4.406M |
March 31, 2017 | 4.657M |
December 31, 2016 | 4.755M |
September 30, 2016 | 4.666M |
June 30, 2016 | 4.547M |
March 31, 2016 | 4.793M |
December 31, 2015 | 4.882M |
September 30, 2015 | 4.334M |
June 30, 2015 | 3.977M |
March 31, 2015 | 4.60M |
December 31, 2014 | 4.838M |
September 30, 2014 | 4.073M |
June 30, 2014 | 3.853M |
March 31, 2014 | 3.994M |
December 31, 2013 | 3.981M |
September 30, 2013 | 3.46M |
June 30, 2013 | 3.432M |
March 31, 2013 | 4.751M |
December 31, 2012 | 4.671M |
September 30, 2012 | 4.829M |
June 30, 2012 | 5.832M |
March 31, 2012 | 5.065M |
December 31, 2011 | 5.538M |
September 30, 2011 | 3.811M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.994M
Minimum
Sep 2019
21.40M
Maximum
Dec 2023
9.660M
Average
7.256M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 46.54M |
SELLAS Life Sciences Group Inc | 3.08M |
Johnson & Johnson | 5.257B |
Immuneering Corp | 4.385M |
Moderna Inc | 470.00M |